Antitumor and chemosensitizing action of 3-bromopyruvate: Implication of deregulated metabolism

作者：Yadav Saveg; Pandey Shrish Kumar; Kumar Ajay; Kujur Praveen Kumar; Singh Rana Pratap; Singh Sukh Mahendra^*

来源：Chemico-Biological Interactions, 2017, 270: 73-89.

DOI：10.1016/j.cbi.2017.04.015

• 3-Bromopyruvate
• Thymoma
• Dalton's lymphoma
• Metabolism
• Cell survival
• Apoptosis
• Necrosis

3-Bromopyruvate (3-BP), brominated derivative of pyruvate, possesses strong antitumor potential, owing to its ability to inhibit multiple target molecules crucial for survival of neoplastic cells. Although, 3-BP displays cytotoxicity against a wide variety of tumors, there is no report with respect to malignancies of thymic origin. Therefore, we investigated its antineoplastic action in vitro against tumor cells of a murine transplantable lymphoma of thymoma origin, designated as Dalton's lymphoma (DL). 3-BP treatment of tumor cells inhibited metabolism and survival with augmented induction of apoptosis and necrosis. 3-BP treatment suppressed lactate release, glucose uptake, deregulated pH homeostasis and augmented chemosensitization. It also altered expression of metabolism, chemosensitivity and cell survival regulatory molecules including HK 2, GAPDH, LDH, SDH, HIF-1 alpha, MDR-1 & GLUT-1 and cytokine repertoire of IFN-gamma, IL-6, IL-10, & VEGF. Pretreatment with MCT-1 inhibitor alpha-cyano-4-hydroxycinnamate and siRNA gene silencing of HK 2 implicated the role of MCT-1 and HK 2 in 3-BP cytotoxicity. 3-BP also altered expression of cell death regulatory Bcl-2, Mcl-1, caspase-3 accompanied by increased cytochrome c release, indicating mitochondrial mode of cell death. The study collates possible molecular mechanisms of cytotoxic action of 3-BP, which will help to optimize the therapeutic efficacy of 3-BP against tumors of thymic origin.

• 出版日期2017-5-25